Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1998 1
2004 1
2006 1
2007 1
2008 1
2009 2
2010 1
2012 2
2013 1
2014 1
2017 4
2018 2
2019 5
2020 1
2021 3
Text availability
Article attribute
Article type
Publication date

Search Results

25 results
Results by year

Citations

1 article found by citation matching

Search results

Filters applied: . Clear all
Page 1
Your search for Impact of Secondary Prevention in an Occupational High-Risk Group retrieved no results
Impact of Secondary Prevention in an Occupational High-Risk Group.
Welch LS, Dement J, Ringen K, Cranford K, Quinn PS. Welch LS, et al. J Occup Environ Med. 2017 Jan;59(1):67-73. doi: 10.1097/JOM.0000000000000925. J Occup Environ Med. 2017. PMID: 28045800
METHODS: We compared results from the initial examination to follow-up examinations delivered at least 3 years after the initial examination for the following outcomes: body mass index (BMI); total serum cholesterol; nonhigh-density lipoprotein (non-HDL) cholesterol; hemoglobin A …
METHODS: We compared results from the initial examination to follow-up examinations delivered at least 3 years after the initial examination …
Workplace interventions for increasing standing or walking for decreasing musculoskeletal symptoms in sedentary workers.
Parry SP, Coenen P, Shrestha N, O'Sullivan PB, Maher CG, Straker LM. Parry SP, et al. Cochrane Database Syst Rev. 2019 Nov 17;2019(11):CD012487. doi: 10.1002/14651858.CD012487.pub2. Cochrane Database Syst Rev. 2019. PMID: 31742666 Free PMC article.
BACKGROUND: The prevalence of musculoskeletal symptoms among sedentary workers is high. Interventions that promote occupational standing or walking have been found to reduce occupational sedentary time, but it is unclear whether these interventions ameliorate …
BACKGROUND: The prevalence of musculoskeletal symptoms among sedentary workers is high. Interventions that promote occupational
Real-time optimized biofeedback utilizing sport techniques (ROBUST): a study protocol for a randomized controlled trial.
Taylor JB, Nguyen AD, Paterno MV, Huang B, Ford KR. Taylor JB, et al. BMC Musculoskelet Disord. 2017 Feb 7;18(1):71. doi: 10.1186/s12891-017-1436-1. BMC Musculoskelet Disord. 2017. PMID: 28173788 Free PMC article. Clinical Trial.
BACKGROUND: Anterior cruciate ligament (ACL) injuries in female athletes lead to a variety of short- and long-term physical, financial, and psychosocial ramifications. While dedicated injury prevention training programs have shown promise, ACL injury rates remain high
BACKGROUND: Anterior cruciate ligament (ACL) injuries in female athletes lead to a variety of short- and long-term physical, financial, and …
The use of exoskeletons in the occupational context for primary, secondary, and tertiary prevention of work-related musculoskeletal complaints.
Steinhilber B, Luger T, Schwenkreis P, Middeldorf S, Bork H, Mann B, von Glinski A, Schildhauer TA, Weiler S, Schmauder M, Heinrich K, Winter G, Schnalke G, Frener P, Schick R, Wischniewski S, Jäger M. Steinhilber B, et al. IISE Trans Occup Ergon Hum Factors. 2020 Jul-Sep;8(3):132-144. doi: 10.1080/24725838.2020.1844344. Epub 2020 Nov 30. IISE Trans Occup Ergon Hum Factors. 2020. PMID: 33140996
Purpose: This guideline provided recommendations for potential applications of exoskeletons in the workplace for the primary, secondary, and tertiary prevention of musculoskeletal complaints and diseases, general recommendations on the use and implementation of exos …
Purpose: This guideline provided recommendations for potential applications of exoskeletons in the workplace for the primary, secondary
Non-pharmacological interventions for preventing venous insufficiency in a standing worker population.
Robertson L, Yeoh SE, Kolbach DN. Robertson L, et al. Cochrane Database Syst Rev. 2013 Oct 15;2013(10):CD006345. doi: 10.1002/14651858.CD006345.pub3. Cochrane Database Syst Rev. 2013. PMID: 24127117 Free PMC article. Review.
OBJECTIVES: To assess the efficacy of non-pharmacological strategies and devices to prevent CVI in a standing worker population. SEARCH METHODS: For this update the Cochrane Peripheral Vascular Diseases Group Trials Search Co-ordinator searched the Specialised Regis …
OBJECTIVES: To assess the efficacy of non-pharmacological strategies and devices to prevent CVI in a standing worker population. SEAR …
Non-pharmacological interventions for preventing venous insufficiency in a standing worker population.
Robertson L, Yeoh SE, Kolbach DN. Robertson L, et al. Cochrane Database Syst Rev. 2012 Jan 18;1:CD006345. doi: 10.1002/14651858.CD006345.pub2. Cochrane Database Syst Rev. 2012. PMID: 22258967 Updated. Review.
OBJECTIVES: To undertake a systematic review of randomised or controlled clinical trials to assess the efficacy of non-pharmacological strategies and devices to prevent CVI in a standing worker population. SEARCH METHODS: The Cochrane Peripheral Vascular Diseases (PVD) …
OBJECTIVES: To undertake a systematic review of randomised or controlled clinical trials to assess the efficacy of non-pharmacological strat …
Cancer prevention: past, present, future.
Sugimura T. Sugimura T. Mutat Res. 1998 Jun 18;402(1-2):7-14. doi: 10.1016/s0027-5107(97)00276-5. Mutat Res. 1998. PMID: 9675231 Review.
However, a single mutation yielding genomic instability exerts a disproportionately large influence by resulting in a large number of secondary mutational events. Epigenetic changes can also not be disregarded especially from the view point of prevention of neoplasi …
However, a single mutation yielding genomic instability exerts a disproportionately large influence by resulting in a large number of sec
The Role of Prevention in Reducing the Economic Impact of ME/CFS in Europe: A Report from the Socioeconomics Working Group of the European Network on ME/CFS (EUROMENE).
Pheby DFH, Araja D, Berkis U, Brenna E, Cullinan J, de Korwin JD, Gitto L, Hughes DA, Hunter RM, Trepel D, Wang-Steverding X. Pheby DFH, et al. Medicina (Kaunas). 2021 Apr 16;57(4):388. doi: 10.3390/medicina57040388. Medicina (Kaunas). 2021. PMID: 33923830 Free PMC article.
The exception is in the use of agricultural chemicals, particularly organophosphates, where there is scope for intervention, and where Europe-wide programmes of health education to encourage safe use would be beneficial. There is a need for more research on risk factors fo …
The exception is in the use of agricultural chemicals, particularly organophosphates, where there is scope for intervention, and where Europ …
Impact of intermediate to high doses of methylprednisolone on mortality rate in patients with COVID-19 pneumonia-induced severe systemic inflammation.
Climente-Martí M, Ruiz-Millo O, López-Cruz I, Atienza-García Á, Martínez-Moragón E, Garijo-Gómez E, López-Grima ML, Zaragoza-Crespo R, Llau-Pitarch JV, Bautista-Rentero D, Nogueira-Coito JM, Ripollés-González T, Marco-Artal MA, Romero-Serrano R, Dolz-Sinisterra F, López-Estudillo R; Doctor Peset COVID-19 Working Group. Climente-Martí M, et al. Int J Clin Pract. 2021 Sep;75(9):e14479. doi: 10.1111/ijcp.14479. Epub 2021 Jun 28. Int J Clin Pract. 2021. PMID: 34107137 Free PMC article.
Kaplan-Meier method and Cox proportional hazard regression were implemented to analyse the time to event outcomes. RESULTS: A total of 142 patients (corticosteroid group n = 72, control group n = 70) were included. A significant reduction in 28-day all-cause mortali …
Kaplan-Meier method and Cox proportional hazard regression were implemented to analyse the time to event outcomes. RESULTS: A total of 142 p …
[The PreFord Study. A prospective cohort study to evaluate the risk of a cardiovascular event (overall-collective) as well as a prospective, randomized, controlled, multicentre clinical intervention study (high-risk-collective) on primary prevention of cardiovascular diseases in the Ford Motor Company employees in Germany].
Gysan DB, Latsch J, Bjarnason-Wehrens B, Albus C, Falkowski G, Herold G, Mey E, Heinzler R, Montiel G, Schneider CA, Stützer H, Türk S, Weisbrod M, Predel HG. Gysan DB, et al. Z Kardiol. 2004 Feb;93(2):131-6. doi: 10.1007/s00392-004-0990-3. Z Kardiol. 2004. PMID: 14963679 Clinical Trial. German.

Based on these data participants will be differentiated into three risk-groups according to the risk score of the European Society of Cardiology (risk of a lethal primary acute cardiovascular event: I < or = 1%; II > 1-< 5% and III > or = 5

Based on these data participants will be differentiated into three risk-groups according to the risk score of the Europ …
25 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page